BSE filing, NSE: SANDUPHQ. Summary written from the filing by ALFA Finder's alert engine.
Sandu Pharmaceuticals Ltd: key numbers
- Share price
- ₹35.95
- Market cap
- ₹34.73 Cr
- Revenue (annual)
- ₹69.93 Cr
- Net profit (annual)
- ₹1.77 Cr
- P/E (TTM)
- 14.3×Sector 45.9×
- Promoter holding
- 37.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandu Pharmaceuticals Ltd
All →Sandu Pharmaceuticals Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals intimated that Non-Executive Independent Director Dr Neeti Madan Kapre has changed her name to Dr Neeti Gupta after marriage. The DIN, designation and directorship remain unchanged.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals Limited has issued a reminder to physical shareholders regarding the mandatory submission of PAN and KYC details. This compliance follow-up aims to facilitate electronic dividend payments.
Sandu Pharmaceuticals Management Change
Sandu Pharmaceuticals appointed Dr. Neeti Madan Kapre as director and Dave & Dave as statutory auditor, while announcing other board and auditor tenure changes.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals has appointed M/s. Dave & Dave as Statutory Auditors for a five-year term, following the tenure expiry of the previous auditors.
Sandu Pharmaceuticals Annual General Meeting
Sandu Pharmaceuticals Limited held its 41st Annual General Meeting on September 11, 2026, via video conferencing to transact ordinary and special business items.
Other board meeting date announcements
All →Purple United Sales Board Meeting Date
Purple United Sales will hold a board meeting on 6 November 2026 to approve half-yearly unaudited results and consider fund raising. The fund raise is through debt issue, and the trading window is closed until 8 November 2026.
Capital India Finance Board Meeting Date
Capital India Finance will hold a board meeting on 6 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results are declared.
Laxmi Goldorna House Board Meeting Date
Laxmi Goldorna House Limited intimated a board meeting on 06 Nov 2026 to consider unaudited quarterly results for the period ended September 2026. The trading window is closed from 01 Oct 2026 until 48 hours after results.
Atma Industries Board Meeting Date
Atma Industries gave prior intimation of its 04 November 2026 board meeting to consider unaudited results for the quarter and half year ended 30 September 2026. The filing also notes the trading window closes from 01 October 2026.
Diana Tea Company Board Meeting Date
Diana Tea Company will hold a board meeting on 5 November 2026 to consider unaudited quarterly and half-yearly results for September 2026. The trading window stays closed from 1 October 2026 until 48 hours after the results are declared.
Cospower Engineering Board Meeting Date
CosPower Engineering will hold a board meeting on 4 November 2026 to consider half-year standalone results. The notice is advance intimation; agenda items are only proposed.